When was NEUROPHET founded?

NEUROPHET was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Where is NEUROPHET located?

NEUROPHET is headquartered in Seoul, South Korea.

Who is the current CEO of NEUROPHET?

Junkil Been of NEUROPHET. They have also founded 1 company.

How many employees does NEUROPHET have?

As of Mar 31, 2026, the latest employee count at NEUROPHET is 79.

Is NEUROPHET a funded company?

NEUROPHET is a funded company, having raised a total of $45.9M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Nov 26, 2019.

When was the latest funding round of NEUROPHET?

NEUROPHET's latest funding was a $***** Series C round on Apr 13, 2026, with participation from 2 investors.

Where does NEUROPHET rank among its competitors?

NEUROPHET ranks 10th amongst 78 active competitors, of which 31 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Brainomix, which secured $6.5M in Feb, 2026.

Who are the top competitors of NEUROPHET?

NEUROPHET's top competitors include Viz.ai, Brainomix and RapidAI. Among them, NEUROPHET secured the most recent funding round in April, 2026.

NEUROPHET - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation. It is developing simulation software in neuro-engineering that is specialized for doctors and researchers in electrical brain stimulation (EBS). Its users can generate an individual 3D brain model by MRI, and simulate and analyze the potential effects of EBS in the various parameters of treatment in a clinical setting. It helps with full-automatic 3D brain model generation for each patient.

Website: www.neurophet.com/en
Social
Email ID: *****@neurophet.com
Phone Number: +82 **********

Key Metrics

Founded Year

2016

Location

Seoul, South Korea

Stage

Public

Total Funding

$45.9M in 5 rounds

Latest Funding Round

Series C, Apr 13, 2026, $*****

Investors

SBI Investment Korea & 15 more

Ranked

10^th among 78 active competitors

Employee Count

79 as on Mar 31, 2026

Similar Companies

Innovaccer & 2366 more

Exit Details

Public

View NEUROPHET's full profile

NEUROPHET is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Neurofit Co., Ltd. CIN: 204-86-57415 , South Korea, Active	Mar 13, 2016	$1.63M (As on Dec 31, 2024)	-	-

NEUROPHET got listed on Jul 25, 2025.

Click here to take a look at NEUROPHET's IPO in detail

NEUROPHET has raised a total funding of $45.9M over 5 rounds. Its first funding round was on Nov 26, 2019. Its latest funding round was a Series C round on Apr 13, 2026 for $*****. 2 investors participated in its latest round. NEUROPHET has 16 institutional investors.

Here is the list of recent funding rounds of NEUROPHET:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 13, 2026	9802928	Series C	9812675	7561619	9246948	4829248
Mar 04, 2024	6335371	Series B	7202852	1488588	6648993	6680034
Nov 08, 2021	7620773	Series B	9057592	5356752	SBI Investment Korea & 5 more	9100815

Access funding benchmarks and valuations. Sign up today!

View details of NEUROPHET's funding rounds and investors

The founders of NEUROPHET is Junkil Been. Junkil Been is the CEO of NEUROPHET.

Here are the details of NEUROPHET's key team members:

Junkil Been: Co-Founder & Co-CEO of NEUROPHET.

View details of NEUROPHET's Founder profiles and Board Members

NEUROPHET's employee count trend

NEUROPHET has 79 employees as of Mar 26. Here is NEUROPHET's employee count trend over the years:

Uncover NEUROPHET's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NEUROPHET include Viz.ai, Brainomix and RapidAI. Here is the list of Top 10 competitors of NEUROPHET, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Viz.ai 2016, San Francisco (United States), Series D	Provider of AI-powered care coordination platform for disease detection and treatment	$252M	Insight Partners, Kleiner Perkins & 16 others	69/100
2nd	Brainomix 2010, Oxford (United Kingdom), Series C	Developer of AI-powered medical imaging software for disease assessment and treatment	$59.3M	Parkwalk, Boehringer Ingelheim Venture Fund ... & 11 others	61/100
3rd	RapidAI 2012, San Mateo (United States), Series C	Developer of clinical AI platform enhancing medical imaging and stroke care	$100M	Lennertz, Vistacreditpartners & 2 others	57/100
4th	Cerebriu 2018, Copenhagen (Denmark), Series A	AI-based imaging software for the diagnosis of brain disease	$29.5M	North Ventures, Innovationsfonden & 9 others	56/100
5th	BrainSightAI 2019, Bengaluru (India), Seed	AI based platform offering connectomics for functional brain mapping	$6.65M	Pfizer, Indian Angel Network & 50 others	55/100
6th	Pixyl 2015, La Tronche (France), Acquired	Developer of AI tools for neuroimage analysis for clinicians	$3.19M	Elaia, IT-Translation & 6 others	54/100
7th	heuron 2019, Incheon (South Korea), Series B	Provider of AI-based clinical diagnosis software for doctors	$13.4M	SBVA, Positive Investment & 2 others	53/100
8th	icometrix 2011, Leuven (Belgium), Acquired	Provider of an AI based software for analysis of brain MRI images	$20.2M	Forestay Capital, Capricorn Partners & 9 others	52/100
9th	LVIS 2011, Palo Alto (United States), Series B	AI powered EEG analysis platform for neurological disease diagnosis	$18M	SK, SK Networks & 4 others	52/100
10th	NEUROPHET 2016, Seoul (South Korea), Public	Developer of AI-based simulation software for doctors and researchers in electrical brain stimulation	$45.9M	Philips HealthWorks, Kolon Investments & 14 others	61/100